Reduced ileal expression of OSTα-OSTβ in non-obese gallstone disease

Cholelithiasis is a multifactorial process, and several mechanisms have been postulated. A decreased expression of the ileal apical sodium-dependent bile acid transporter (ASBT) and of the cytosolic ileal lipid binding protein (ILBP) was recently described in female non-obese patients. The role of t...

Full description

Bibliographic Details
Main Authors: Olga Renner, Simone Harsch, André Strohmeyer, Silke Schimmel, Eduard F. Stange
Format: Article
Language:English
Published: Elsevier 2008-09-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520346721
_version_ 1819293798674464768
author Olga Renner
Simone Harsch
André Strohmeyer
Silke Schimmel
Eduard F. Stange
author_facet Olga Renner
Simone Harsch
André Strohmeyer
Silke Schimmel
Eduard F. Stange
author_sort Olga Renner
collection DOAJ
description Cholelithiasis is a multifactorial process, and several mechanisms have been postulated. A decreased expression of the ileal apical sodium-dependent bile acid transporter (ASBT) and of the cytosolic ileal lipid binding protein (ILBP) was recently described in female non-obese patients. The role of the recently identified organic solute transporters α and β (OSTα, OSTβ) in gallstone pathogenesis remains unclear. Therefore, we performed analysis of OSTα-OSTβ in gallstone patients according to body weight. Ileal mucosal biopsies were collected during routine colonoscopy from female gallstone carriers (n = 19) and controls (n = 34). OSTα-OSTβ mRNA expression was measured using the LightCycler sequence detection system; protein was analyzed by immunohistochemistry and Western blot. The mRNA expression of OSTα-OSTβ was significantly reduced (OSTα: 3.3-fold, P = 0.006; OSTβ: 2.6-fold, P = 0.03) in normal-weight but not overweight gallstone carriers compared with controls. OSTα-OSTβ protein levels also showed a reduction by 40–67%. The expression of OSTα-OSTβ correlated positively with ASBT (r = 0.65, 0.58, respectively), ILBP (r = 0.77, 0.67), and the farnesoid X receptor (r = 0.58, 0.50). Fibroblast growth factor-19 showed a 2.8-fold reduction (P = 0.06), and liver receptor homolog-1 showed a 2-fold reduction (P = 0.04) in non-obese patients. In conclusion, an impaired function of all three ileal bile acid transporters may lead to low ileal bile acid reabsorption and an altered bile acid pool composition and therefore may contribute to the formation of gallstones in non-obese patients.
first_indexed 2024-12-24T04:16:09Z
format Article
id doaj.art-4219762d2fd04ab2b916d478091a413a
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-24T04:16:09Z
publishDate 2008-09-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-4219762d2fd04ab2b916d478091a413a2022-12-21T17:15:56ZengElsevierJournal of Lipid Research0022-22752008-09-0149920452054Reduced ileal expression of OSTα-OSTβ in non-obese gallstone diseaseOlga Renner0Simone Harsch1André Strohmeyer2Silke Schimmel3Eduard F. Stange4Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart and University of Tübingen, GermanyDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart and University of Tübingen, GermanyDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart and University of Tübingen, GermanyDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart and University of Tübingen, GermanyDepartment of Internal Medicine I, Robert-Bosch-Hospital, Stuttgart, GermanyCholelithiasis is a multifactorial process, and several mechanisms have been postulated. A decreased expression of the ileal apical sodium-dependent bile acid transporter (ASBT) and of the cytosolic ileal lipid binding protein (ILBP) was recently described in female non-obese patients. The role of the recently identified organic solute transporters α and β (OSTα, OSTβ) in gallstone pathogenesis remains unclear. Therefore, we performed analysis of OSTα-OSTβ in gallstone patients according to body weight. Ileal mucosal biopsies were collected during routine colonoscopy from female gallstone carriers (n = 19) and controls (n = 34). OSTα-OSTβ mRNA expression was measured using the LightCycler sequence detection system; protein was analyzed by immunohistochemistry and Western blot. The mRNA expression of OSTα-OSTβ was significantly reduced (OSTα: 3.3-fold, P = 0.006; OSTβ: 2.6-fold, P = 0.03) in normal-weight but not overweight gallstone carriers compared with controls. OSTα-OSTβ protein levels also showed a reduction by 40–67%. The expression of OSTα-OSTβ correlated positively with ASBT (r = 0.65, 0.58, respectively), ILBP (r = 0.77, 0.67), and the farnesoid X receptor (r = 0.58, 0.50). Fibroblast growth factor-19 showed a 2.8-fold reduction (P = 0.06), and liver receptor homolog-1 showed a 2-fold reduction (P = 0.04) in non-obese patients. In conclusion, an impaired function of all three ileal bile acid transporters may lead to low ileal bile acid reabsorption and an altered bile acid pool composition and therefore may contribute to the formation of gallstones in non-obese patients.http://www.sciencedirect.com/science/article/pii/S0022227520346721gallstonesintestineorganic solute transporters α and βfarnesoid X receptorfibroblast growth factor-19liver receptor homolog-1
spellingShingle Olga Renner
Simone Harsch
André Strohmeyer
Silke Schimmel
Eduard F. Stange
Reduced ileal expression of OSTα-OSTβ in non-obese gallstone disease
Journal of Lipid Research
gallstones
intestine
organic solute transporters α and β
farnesoid X receptor
fibroblast growth factor-19
liver receptor homolog-1
title Reduced ileal expression of OSTα-OSTβ in non-obese gallstone disease
title_full Reduced ileal expression of OSTα-OSTβ in non-obese gallstone disease
title_fullStr Reduced ileal expression of OSTα-OSTβ in non-obese gallstone disease
title_full_unstemmed Reduced ileal expression of OSTα-OSTβ in non-obese gallstone disease
title_short Reduced ileal expression of OSTα-OSTβ in non-obese gallstone disease
title_sort reduced ileal expression of ostα ostβ in non obese gallstone disease
topic gallstones
intestine
organic solute transporters α and β
farnesoid X receptor
fibroblast growth factor-19
liver receptor homolog-1
url http://www.sciencedirect.com/science/article/pii/S0022227520346721
work_keys_str_mv AT olgarenner reducedilealexpressionofostaostbinnonobesegallstonedisease
AT simoneharsch reducedilealexpressionofostaostbinnonobesegallstonedisease
AT andrestrohmeyer reducedilealexpressionofostaostbinnonobesegallstonedisease
AT silkeschimmel reducedilealexpressionofostaostbinnonobesegallstonedisease
AT eduardfstange reducedilealexpressionofostaostbinnonobesegallstonedisease